Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Pneumothorax | Research article

A novel finding related to bulla and bleb formation in patients with primary spontaneous pneumothorax

Authors: Akira Iyoda, Yoko Azuma, Takashi Sakai, Satoshi Koezuka, Hajime Otsuka, Atsushi Sano

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Spontaneous pneumothorax is a common problem globally. Bullas and blebs have been implicated in this problem, but the etiology of their formation is unknown. We aim to show the relation between a novel clinical finding, the pulmonary delayed inflation (PDI) sign, and the etiology of bulla and bleb formation in young patients.

Methods

We retrospectively analyzed data from 111 patients with pneumothorax and a control group of 27 patients. We evaluated the relation between the PDI sign and other clinical factors.

Results

The PDI sign was observed in 78 patients. Of these, 75 exhibited the PDI sign in only the upper lobe. Regardless of smoking status, patients 34 years of age or younger had a significantly higher incidence of the PDI sign than, patients 55 years of age or older and control patients. The inflation time in patients 34 years of age or younger, regardless of smoking status, was significantly longer than in patients 55 years of age or older and patients in the control group. There was no significant association between inflation time and the presence of asthma.

Conclusions

The novel PDI sign is seen in patients 34 years of age or younger. Because this sign may indicate a peripheral bronchial abnormality and may be related to the formation of blebs and bullae in young patients with spontaneous pneumothorax, it is possible that it can be used to develop effective treatments for pneumothorax in young patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hallifax RJ, Goldacre R, Landray MJ, Rahman NM, Goldacre MJ. Trends in the incidence and recurrence of inpatient-treated spontaneous pneumothorax, 1968–2016. JAMA. 2018;320:1471–80.CrossRef Hallifax RJ, Goldacre R, Landray MJ, Rahman NM, Goldacre MJ. Trends in the incidence and recurrence of inpatient-treated spontaneous pneumothorax, 1968–2016. JAMA. 2018;320:1471–80.CrossRef
2.
go back to reference Bobbio A, Dechartres A, Bouam S, et al. Epidemiology of spontaneous pneumothorax: gender-related differences. Thorax. 2015;70:653–8.CrossRef Bobbio A, Dechartres A, Bouam S, et al. Epidemiology of spontaneous pneumothorax: gender-related differences. Thorax. 2015;70:653–8.CrossRef
3.
go back to reference Gupta D, Hansell A, Nichols T, Duong T, Ayres JG, Strachan D. Epidemiology of pneumothorax in England. Thorax. 2000;55:666–71.CrossRef Gupta D, Hansell A, Nichols T, Duong T, Ayres JG, Strachan D. Epidemiology of pneumothorax in England. Thorax. 2000;55:666–71.CrossRef
4.
go back to reference Bintcliffe OJ, Hallifax RJ, Edey A, et al. Spontaneous pneumothorax: time to rethink management? Lancet Respir Med. 2015;3:578–88.CrossRef Bintcliffe OJ, Hallifax RJ, Edey A, et al. Spontaneous pneumothorax: time to rethink management? Lancet Respir Med. 2015;3:578–88.CrossRef
5.
go back to reference Plojoux J, Froudarakis M, Janssens JP, Soccal PM, Tschopp JM. New insights and improved strategies for the management of primary spontaneous pneumothorax. Clin Respir J. 2019;13:195–201.CrossRef Plojoux J, Froudarakis M, Janssens JP, Soccal PM, Tschopp JM. New insights and improved strategies for the management of primary spontaneous pneumothorax. Clin Respir J. 2019;13:195–201.CrossRef
6.
go back to reference Fujino S, Inoue S, Tezuka N, et al. Physical development of surgically treated patients with primary spontaneous pneumothorax. Chest. 1999;116:899–902.CrossRef Fujino S, Inoue S, Tezuka N, et al. Physical development of surgically treated patients with primary spontaneous pneumothorax. Chest. 1999;116:899–902.CrossRef
7.
go back to reference Noppen M. Spontaneous pneumothorax: epidemiology, pathophysiology and cause. Eur Respir Rev. 2010;19:217–9.CrossRef Noppen M. Spontaneous pneumothorax: epidemiology, pathophysiology and cause. Eur Respir Rev. 2010;19:217–9.CrossRef
8.
go back to reference Cottin V, Streichenberger N, Gamondès JP, Thévenet F, Loire R, Cordier JF. Respiratory bronchiolitis in smokers with spontaneous pneumothorax. Eur Respir J. 1998;12:702–4.CrossRef Cottin V, Streichenberger N, Gamondès JP, Thévenet F, Loire R, Cordier JF. Respiratory bronchiolitis in smokers with spontaneous pneumothorax. Eur Respir J. 1998;12:702–4.CrossRef
9.
go back to reference Morrison PJ, Lowry RC, Nevin NC. Familial primary spontaneous pneumothorax consistent with true autosomal dominant inheritance. Thorax. 1998;53:151–2.CrossRef Morrison PJ, Lowry RC, Nevin NC. Familial primary spontaneous pneumothorax consistent with true autosomal dominant inheritance. Thorax. 1998;53:151–2.CrossRef
10.
go back to reference Bense L, Eklund G, Wiman LG. Bilateral bronchial anomaly. A pathogenetic factor in spontaneous pneumothorax. Am Rev Respir Dis. 1992;146:513–6.CrossRef Bense L, Eklund G, Wiman LG. Bilateral bronchial anomaly. A pathogenetic factor in spontaneous pneumothorax. Am Rev Respir Dis. 1992;146:513–6.CrossRef
11.
go back to reference Noppen M, Dekeukeleire T, Hanon S, et al. Fluorescein-enhanced autofluorescence thoracoscopy in patients with primary spontaneous pneumothorax and normal subjects. Am J Respir Crit Care Med. 2006;174:26–30.CrossRef Noppen M, Dekeukeleire T, Hanon S, et al. Fluorescein-enhanced autofluorescence thoracoscopy in patients with primary spontaneous pneumothorax and normal subjects. Am J Respir Crit Care Med. 2006;174:26–30.CrossRef
12.
go back to reference Withers JN, Fishback ME, Kiehl PV, Hannon JL. Spontaneous pneumothorax. Suggested etiology and comparison of treatment methods. Am J Surg. 1964;108:772–6.CrossRef Withers JN, Fishback ME, Kiehl PV, Hannon JL. Spontaneous pneumothorax. Suggested etiology and comparison of treatment methods. Am J Surg. 1964;108:772–6.CrossRef
13.
go back to reference Kawakami Y, Irie T, Kamishima K. Stature, lung height, and spontaneous pneumothorax. Respiration. 1982;43:35–40.CrossRef Kawakami Y, Irie T, Kamishima K. Stature, lung height, and spontaneous pneumothorax. Respiration. 1982;43:35–40.CrossRef
14.
go back to reference Coxson HO, Chan IHT, Mayo JR, Hlynsky J, Nakano Y, Birmingham CL. Early emphysema in patients with anorexia nervosa. Am J Respir Crit Care Med. 2004;170:748–52.CrossRef Coxson HO, Chan IHT, Mayo JR, Hlynsky J, Nakano Y, Birmingham CL. Early emphysema in patients with anorexia nervosa. Am J Respir Crit Care Med. 2004;170:748–52.CrossRef
15.
go back to reference Neptune ER, Frischmeyer PA, Arking DE, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003;33:407–11.CrossRef Neptune ER, Frischmeyer PA, Arking DE, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003;33:407–11.CrossRef
16.
go back to reference Tanaka F, Itoh M, Esaki H, Isobe J, Ueno Y, Inoue R. Secondary spontaneous pneumothorax. Ann Thorac Surg. 1993;55:372–6. Tanaka F, Itoh M, Esaki H, Isobe J, Ueno Y, Inoue R. Secondary spontaneous pneumothorax. Ann Thorac Surg. 1993;55:372–6.
17.
go back to reference O’Rourke JP, Yee ES. Civilian spontaneous pneumothorax. Treatment options and long-term results Chest. 1989;96:1302–6.PubMed O’Rourke JP, Yee ES. Civilian spontaneous pneumothorax. Treatment options and long-term results Chest. 1989;96:1302–6.PubMed
18.
go back to reference Porpodis K, Zarogoulidis P, Spyratos D, et al. Pneumothorax and asthma J Thorac Dis. 2014;6:S152-161.PubMed Porpodis K, Zarogoulidis P, Spyratos D, et al. Pneumothorax and asthma J Thorac Dis. 2014;6:S152-161.PubMed
Metadata
Title
A novel finding related to bulla and bleb formation in patients with primary spontaneous pneumothorax
Authors
Akira Iyoda
Yoko Azuma
Takashi Sakai
Satoshi Koezuka
Hajime Otsuka
Atsushi Sano
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01402-z

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.